No Prescription |
 |
 | ||
|
Zocor |
|
| ||
No Prescription » Prescription Drugs 17 » Zocor Medical Information:Simvastatin is used with diet changes (restriction of cholesterol and fat intake) to reduce the amount of cholesterol and certain fatty substances in your blood. Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and therefore the oxygen supply to your heart brain and other parts of your body.Simvastatin used with diet modification to lower cholesterol levels in type IIa and IIb hypercholesterolemia in those with a significant risk of coronary artery disease who have not responsded to other measure.Simvastatin used to increase HDL cholesterol.Hypercholesterolaemia. High risk of coronary heart disease. Heterozygous familial hypercholesterolaemia (FH) in children. Lowering blood cholesterol levels and thereby reducing the risk of stroke heart attack and heart disease. Simvastatin is a cholesterol-lowering medication that blocks the production of cholesterol (a type of fat) in the body. Simvastatin reduces low-density lipoprotein (LDL) cholesterol and total cholesterol in the blood. Lowering your cholesterol can help prevent heart disease. Buy Zocor and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About Zocor: Product Type: Prescription Drugs 17 Zocor/Lipex ( Generic Simvastatin ) Zocor/Lipex (Generic Simvastatin) Generic Simvastatin 10mg 30 Tablets 10mg 90(3 x 30) Tablets 20mg 90(3 x 30) Tablets 20mg 30 Tablets 40mg 30 Tablets 40mg 90(3 x 30) Tablets 80mg 90(3 x 30) Tablets 80mg 30 Tablets Generic Simvastatin Zocor/Lipex
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
